colour doppler ultrasound pregnancy in hindi manufacturers

#Colour doppler ultrasound pregnancy in hindi manufacturers skin

This retrospective study was approved by the Ethics Committee of the China-Japan Union Hospital of Jilin University, and all patients signed an informed consent form before undergoing MWA. Therefore, this study aimed to clarify the efficacy of MWA for the treatment of BTNs in a follow-up of at least 48 months. However, as a slowly progressing disease ( 12), the real efficacy of MWA treatment for BTNs should be observed in a long-term follow-up of more than 12 months. In recent years, the short-term (less than 12 months) effects of MWA for the treatment of BTNs have been verified by some scholars with encouraging results, with a volume reduction rate (VRR) that ranges from 45.99% to 85.97% ( 6, 9, 11). MWA is a promising thermal ablation technique that has been used in tumours of the liver and kidney ( 7, 8) due to its continuously higher intratumor temperature and greater ablation range in a shorter ablation time ( 9, 10). One such method is ultrasound (US)-guided percutaneous microwave ablation (MWA) ( 6). Therefore, in recent years, several scholars have sought minimally invasive treatment (MIT) methods to treat benign thyroid nodules (BTNs). Moreover, some patients must be placed on long-term thyroid hormone replacement therapy after surgery ( 3– 5). Although surgery is a widely used and effective treatment regimen, it is traumatic, that results in a slow recovery and affects the appearance of the patient. Only a few of these benign nodules require treatment, due to nodules tend to grow and/or associated pressure and/or clinically symptomatic etc.

In recent years, the detection rate of thyroid nodules has been as high as 65%, and more than 90% of nodules are benign ( 1, 2).

#Colour doppler ultrasound pregnancy in hindi manufacturers skin

No cases of oesophageal injury, tracheal injury, infection, skin burns, etc., were reported during or after MWA.Ĭonclusions: Based on a long-term follow-up, MWA is an effective method for treating BTNs and is expected to be a potential first-line treatment. Five patients experienced complications (3.38%): two patients (1.35%) had bleeding, two patients (1.35%) had ear pain and toothache during MWA, and one patient (0.68%) had hoarseness after MWA. Compared with thyroid function before MWA, no significant variation was observed after MWA. Two patients (1.35%) had recurrence after MWA. Results: The mean volumes of the 148 nodules were 15.6 ± 9.4 cm 3 (range: 1.3-48.9 cm 3) and 0.6 ± 0.6 cm 3 (range: 0-3.5 cm 3) before and 48 months after MWA, respectively, with a nodule VRR of 96.9 ± 2.5% (range: 90.4-100%). The volume, volume reduction rate (VRR), recurrence rate of the ablated area and thyroid function were recorded. Careful ultrasound examinations were performed 1 day, 1 month, 3 months, 6 months, 12 months, and every 6 months after MWA. All patients were from the China-Japan Union Hospital of Jilin University. Methods: From June 2015 to September 2017, 148 patients had 148 BTNs. Our study aim was to assess the long-term results of MWA for BTNs after a 48-month follow-up. However, as a slowly progressing disease, the long-term efficacy of MWA for BTNs at present is not clear. Objectives: The short-term effects of microwave ablation (MWA) for the treatment of benign thyroid nodules (BTNs) were satisfactory in previous studies. 2Department Of Oncology, Hospital of Jilin Bureau of Geologic Exploration and Mineral Development, Changchun, China.1Department of Ultrasound, China-Japan Union Hospital of Jilin University, Changchun, China.Jia-Rui Du 1 Wen-Hui Li 1 Cheng-Hai Quan 2 Hui Wang 1*† Deng-Ke Teng 1*†